Hunan Warrant Pharmaceutical Co. Ltd. A Working Capital to Net Assets Ratio
Hunan Warrant Pharmaceutical Co. Ltd. A working capital to net assets ratio. Hunan Warrant Pharmaceutical Co. Ltd. A (688799) has a Working Capital to Net Assets ratio of 54.7% as of June 2025. Working capital of CN¥1.02 Billion (current assets of CN¥1.35 Billion minus current liabilities of CN¥336.04 Million) is measured against net assets of CN¥1.86 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Hunan Warrant Pharmaceutical Co. Ltd. A (2019–2024)
Working capital to net assets ratio of Hunan Warrant Pharmaceutical Co. Ltd. A from 2019 to 2024. This chart shows how Hunan Warrant Pharmaceutical Co. Ltd. A's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the ratio stands at 54.7%, reflecting working capital of CN¥1.02 Billion against net assets of CN¥1.86 Billion CNY. See 688799 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Hunan Warrant Pharmaceutical Co. Ltd. A Working Capital to Net Assets Ratio by Year (2019–2024)
Hunan Warrant Pharmaceutical Co. Ltd. A working capital to net assets ratio by year from 2019 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Hunan Warrant Pharmaceutical Co. Ltd. A from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 688799 asset base.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 55.6% | CN¥1.01 Billion | CN¥1.82 Billion | CN¥1.43 Billion | CN¥419.02 Million | ▼ -1.7 pp |
| 2023 | 57.3% | CN¥1.01 Billion | CN¥1.77 Billion | CN¥1.35 Billion | CN¥336.38 Million | ▼ -0.2 pp |
| 2022 | 57.5% | CN¥953.50 Million | CN¥1.66 Billion | CN¥1.25 Billion | CN¥294.83 Million | ▼ -6.5 pp |
| 2021 | 64.0% | CN¥946.38 Million | CN¥1.48 Billion | CN¥1.21 Billion | CN¥259.59 Million | ▲ +34.0 pp |
| 2020 | 30.0% | CN¥199.02 Million | CN¥663.05 Million | CN¥422.08 Million | CN¥223.05 Million | ▲ +7.0 pp |
| 2019 | 23.0% | CN¥127.30 Million | CN¥553.17 Million | CN¥395.98 Million | CN¥268.68 Million | — |